Close Menu

NEW YORK (GenomeWeb) – After falling 3 percent in 2016 in what was a dismal year for biotechnology stocks, the GenomeWeb Index surged 39 percent in 2017, led by nearly three-fold gains in the stock prices of Exact Sciences and Foundation Medicine.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Los Angeles brought and settled a civil enforcement action against the makers of an at-home test for SARS-CoV-2, NPR reports. 

The Guardian reports that Cancer Research UK is cutting its research funding by £44 million.

Technology Review examines factors affecting SARS-CoV-2 testing turnaround times.

In PNAS this week: mapping of ancient human migrations in Europe, recurrent gene fusion in breast cancer, and more.